Hybrids & Chimeras
Inheritable Genetic Modification
Medical Gene Transfer
Sequencing & Genomics
Stem Cell Research
Patents & Other IP
A "Post-Human" Future?
Arts & Culture
Biopolitics, Parties & Pundits
Biotech & Pharma
Reproductive Justice, Health & Rights
Stem Cell Research : Displaying 11-20 of 1392
Disgraced stem-cell entrepreneur under fresh investigation
by Alison Abbott
November 14th, 2016
Davide Vannoni was barred from offering a controversial stem-cell therapy in Italy in 2015, but may be continuing his work abroad.
Stem Cell Clinics Promise Miracle Cures, but at What Cost to Patients?
by Philip Perry
November 13th, 2016
Taking advantage of a regulatory loophole, hundreds of clinics with virtually no oversight are offering stem cell therapies which are virtually untested, and make unsubstantiated claims about helping patients overcome disease.
Stem Cell Researchers Anxious About Trump Presidency
by Gillian Mohney
November 11th, 2016
Mike Pence opposes federal funding for embryonic stem cell research. But reintroducing a funding ban "would be like putting a genie back in the bottle."
Fatal experiments: a maverick surgeon strikes back
by Nell Frizzell
October 25th, 2016
A new documentary looks at the six patients who died on Dr. Paolo Macchiarini’s watch. When does pioneering medicine become reckless endangerment?
CRISPR gene-editing controversy shows old ideas about East and West still prevail
by Calvin Wai-Loon Ho
October 24th, 2016
Western imaginations tend to fantasize Asian countries as exotic, crude "others," viewing Chinese research as advancing primarily due to an assumed lack of regulation.
Crispr’s IPO doesn’t hit its target
by Robert Weisman
The Boston Globe
October 19th, 2016
CRISPR Therapeutics' public offering raises half that of its rivals Editas & Intellia -- a sign that the market may be pulling back on genome editing stocks.
California stem cell agency approves $30 million to fast-track clinical trials
by David Jensen
The Sacramento Bee
October 19th, 2016
Dubbed the new "pitching machine," CIRM's new $30 million effort is designed to accelerate clinical trials of stem cell therapies.
What Stem Cell Researchers Talk About When They Talk About Ethics
by Danielle Venton
October 18th, 2016
"Engineers who design something expect it to work. But if you put something [designed] into an organism, the chances that something odd will happen are extremely high."
Mouse eggs made from skin cells in a dish
by David Cyranoski
October 17th, 2016
A research breakthrough sparks debate over the prospect of using stem cell techniques to produce synthetic human eggs from body tissue.
What’s the Longest Humans Can Live? 115 Years, New Study Says
by Carl Zimmer
The New York Times
October 5th, 2016
Despite improvements in modern life and medicine, researchers claim that humans have reached the upper limit of longevity.
Displaying 11-20 of 1392
« First Page
Last Page »
« Show Complete List »
Human Embryonic Stem Cell Research: Frequently Asked Questions and Fact Sheet [PDF]
Next Steps for Stem Cell Research and Related Policies [PDF]
Stem Cell Research in the Midterm Elections
A Pro-Woman Stem-Cell Policy
Potential Conflicts of Interest at the CIRM
Stem Cells on Missouri's Ballot: Much Political Ado, Little Policy Meaning
[ more + ]
Women’s Eggs and Stem Cell Research [PDF]
Reframing the Politics of Stem Cell Research [PDF]
Stem Cell Politics and Progressive Values
Stem Cell Research in California: Lessons Learned [PDF]
Egg Extraction For Stem Cell Research: Issues for Women’s Health
Beyond Embryo Politics
Of Mice, Men and Stem-Cell Research
The California Stem Cell Program at One Year: A Progress Report [PDF]
Eggs vs Ethics in the Stem Cell Debate
Testimony: Stem Cell Research and Intellectual Property
The Other Stem Cell Debate
The California Institute for Regenerative Medicine and Proposition 71 – A Summary
California needs to do more than apologize to people it sterilized
Written evidence for the Genomics and Genome-Editing Inquiry of the House of Commons Science and Technology Committee
How to Watch the Biggest Science Story of 2017
California voters were promised cures. But the state stem cell agency has funded just a trickle of clinical trials
CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 •
• (p) 1.510.665.7760 • (F) 1.510.665.8760